Form 4 for TECH Bio-Techne
Accepted 2026-08-18 17:13:41 ET · period of report 2026-08-15 · accession 0000914190-26-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Hippel James | CFO | M - OptEx | $0.00 | +9,779 | 174.5K | +6% | $0 |
| D | 2026-08-18 17:13 | 2026-08-15 | TECH | Hippel James | CFO | F - Tax | $72.40 | -4,310 | 170.2K | -2% | -$312.0K |
| DM | 2026-08-18 17:13 | 2026-08-15 | TECH | Hippel James | CFO | M - OptEx | $0.00 | -9,779 | 9,807 | -50% | $0 |
| DM | 2026-08-18 17:13 | 2026-08-15 | TECH | Hippel James | CFO | D - Sale to Iss | $0.00 | -48.0K | 2,332 | -95% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | M | A | 9,779 | $0.00 | 174,493 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-15 | F | D | 4,310 | $72.40 | 170,183 | D | — | — | |
| 3 | Derivative | Performance Restricted Stock Units | 2026-08-15 | M | D | 866 | $0.00 | 12,999 | D | — · — to — | 866 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 4 | Derivative | Performance Restricted Stock Units | 2026-08-15 | D | D | 12,999 | $0.00 | 0 | D | — · — to — | 12,999 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. (F3) On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 5 | Derivative | Performance Stock Options (Right to Buy) | 2026-08-15 | D | D | 34,982 | $0.00 | 2,332 | D | $84.61 · — to 2030-08-15 | 34,982 Common Stock | (F4) On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. |
| 6 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 4,010 | $0.00 | 4,011 | D | — · — to — | 4,010 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F7) 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. (F7) 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. |
| 7 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 4,903 | $0.00 | 9,807 | D | — · — to — | 4,903 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F11) 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. (F11) 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. |